MARKET

GRAL

GRAL

Grail Inc
NASDAQ
16.51
+0.13
+0.76%
After Hours: 16.01 -0.5 -3.03% 19:17 11/22 EST
OPEN
16.47
PREV CLOSE
16.38
HIGH
16.63
LOW
15.96
VOLUME
532.25K
TURNOVER
--
52 WEEK HIGH
23.36
52 WEEK LOW
12.33
MARKET CAP
554.58M
P/E (TTM)
-0.2610
1D
5D
1M
3M
1Y
5Y
1D
Grail tests first patient for TROPION-Lung12 Phase 3 study
TipRanks · 5d ago
GRAIL ANNOUNCES FIRST PATIENT TESTED WITH BLOOD-BASED ASSAY IN GLOBAL PHASE 3 ADJUVANT LUNG CANCER STUDY
Reuters · 5d ago
Weekly Report: what happened at GRAL last week (1111-1115)?
Weekly Report · 5d ago
Wolfe starts Grail at Peer Perform on time and money needs
TipRanks · 11/15 11:11
GRAIL 13G Filing Shows Sessa Capital (Master), L.P. Reported A 9.66% Stake In The Co As Of September 30, 2024
Benzinga · 11/14 20:40
SESSA CAPITAL (MASTER), L.P. REPORTS 9.66% PASSIVE STAKE IN GRAIL AS OF SEPT 30 - SEC FILING
Reuters · 11/14 20:38
GRAIL, Inc. Reports Financial Results for the Quarter Ended September 30, 2024
Press release · 11/14 00:03
*Grail 3Q Loss/Shr $3.94 >GRAL
Dow Jones · 11/12 22:15
More
About GRAL
GRAIL, Inc., formerly GRAIL, LLC, is a healthcare company, which is engaged in saving lives and shifting the paradigm in early cancer detection. It is focused on alleviating the global burden of cancer by using next-generation sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its products include Galleri and Beyond. The Galleri test is a commercially available screening test for early detection of multiple types of cancer, which is termed multi-cancer early detection (MCED). Galleri screening test results can help guide next steps for a diagnosis of cancer by healthcare providers.

Webull offers Grail Inc stock information, including NASDAQ: GRAL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRAL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRAL stock methods without spending real money on the virtual paper trading platform.